Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Comparison Between Two Dose Levels of Daunorubicin and Between One Versus Two Cycles of Induction Therapy for Adult Patients With Acute Myeloid Leukemia ≤65 Years

NCT02140242 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT02140242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02140242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Comparison Between Two Dose Levels of Daunorubicin and Between One Versus Two Cycles of Induction Therapy for Adult Patients With Acute Myeloid Leukemia ≤65 Years
Lead sponsor
Technische Universität Dresden
Phase
Phase 3
Overall status
Completed
Start date
April 16, 2014
Completion date
April 25, 2022
Enrollment
721 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, myelocytic, acute